Ignite Creation Date:
2024-05-06 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03591510
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2018-06-25
Brief Title:
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02-15
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-25
First Submit QC Date:
July 7 2018
Study First Post Date:
2018-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-04
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL